A detailed history of Kovitz Investment Group Partners, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Kovitz Investment Group Partners, LLC holds 2,426 shares of CORT stock, worth $183,260. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,426
Holding current value
$183,260
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

BUY
$67.17 - $83.9 $162,954 - $203,541
2,426 New
2,426 $201,000
Q1 2025

May 13, 2025

BUY
$49.85 - $114.22 $90,128 - $206,509
1,808 New
1,808 $206,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $8.09B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Kovitz Investment Group Partners, LLC Portfolio

Follow Kovitz Investment Group Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kovitz Investment Group Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kovitz Investment Group Partners, LLC with notifications on news.